A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin
- Status
- COMPLETED
- Phase
- PHASE3
Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
- Status
- RECRUITING
- Phase
- PHASE2
A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Status
- TEMPORARILY_NOT_AVAILABLE
- Phase
- N/A
A Study to Evaluate the Effect of Food on LOXO-783 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatment of High-Risk Adipocytic Retroperitoneal Sarcoma
- Status
- RECRUITING
- Phase
- PHASE1
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
- Status
- COMPLETED
- Phase
- PHASE1
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Effects of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With Obesity
- Status
- WITHDRAWN
- Phase
- PHASE4
A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty Liver Disease (NAFLD)
- Status
- TERMINATED
- Phase
- PHASE1
A Single and Multiple Ascending Dose Study of LY3876602 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection Devices
- Status
- COMPLETED
- Phase
- PHASE1
TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment
- Status
- COMPLETED
- Phase
- PHASE1
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
- Status
- RECRUITING
- Phase
- PHASE2
Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy
- Status
- RECRUITING
- Phase
- PHASE1